Accu-Chek tests recall
April 24, 2014
Roche Diabetes Care, in
consultation with the Therapeutic
Goods Administration (TGA), is
undertaking a recall for product
correction of its Accu-Chek Mobile
glucose tests due to the potential
for a commonly used antibiotic to
interfere with blood glucose test
results.
It has been found that the
antibiotic ceftriaxone can interfere
with the way the measurement is
made and may lead to incorrect low
blood glucose readings.
Ceftriaxone was a broad-spectrum
antibiotic used to treat a wide
variety of common infections, the
TGA said.
Roche Diabetes Care is advising
users of the Accu-Chek Mobile
meter, a component of the glucose
tests, of this issue and will be
updating the device’s labelling.
The company has said it will
offer affected patients a suitable
alternative blood glucose
measurement system for the
duration of treatment with
ceftriaxone at no charge.
The company said other Roche
blood glucose measurement
systems were not affected by the
recall.
To read more, CLICK HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Apr 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Apr 14
